-
IllumiCare App Recommends Trials as Therapeutic Option, New Data Capture Interface Increases Real-World Patient Compliance, More
Clinical Research News | A 16-gene molecular signature investigation based on gene expression differences between patients with and without local recurrence after breast-conserving surgery; analytically sensitive infectious disease panels to support laboratory research; eClinical solutions to make clinical research processes more efficient and compliant; and more.
Dec 27, 2022
-
Follow the Money: MD Anderson’s High-Affinity Monoclonal Antibody Research, New Neurodegeneration Research Center, More
Clinical Research News | Funding for microbial resistance and infectious disease research, tracking Long COVID in diverse pediatric and adult populations, an AI-powered platform that identifies novel cancer therapies and predicts the efficacy of cancer drug combinations, and more.
Dec 22, 2022
-
ClinEco Helps Trial Stakeholders ‘Cut Through The Noise’ To Find One Another
Clinical Research News | The world’s first B2B market network for clinical trials is now fully functioning and onboarding, as well as learning, from early adopters. ClinEco recently moved into the open beta stage of its development with a gratifyingly diverse mix of stakeholders registering for free membership.
Dec 20, 2022
-
Insilico Medicine’s AI-Driven Platform Pushes The Envelope Of Drug Discovery
Clinical Research News | During a recent virtual unveiling party livestreamed from around the world, Insilico Medicine introduced the latest updates to Pharma.AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials. Among the highlights were the addition of a knowledge graph to target discovery product PandaOmics and numerous new panels to generative chemistry engine Chemistry42.
Dec 15, 2022
